rifacol

Rifaximin is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth.

Rifaximin-D6 (Standard) is a reference standard of Rifaximin-D6 intended for quantitative analysis, quality control, and related biochemical research applications. Rifaximin-d6 is a deuterated compound of Rifaximin. Rifaximin has a CAS number of 80621-81-4. Rifaximin is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth.

Rifaximin-D6 is a deuterated compound of Rifaximin. Rifaximin (T1154) has a CAS number of 80621-81-4. Rifaximin (T1154) is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin (T1154) binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth.

Rifaximin (Standard) is the standard substance of Rifaximin, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Rifaximin is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-dependent RNA polymerase, inhibiting bacterial RNA synthesis and bacterial cell growth.